PURPOSE: To report the prevalence of myopia and high myopia in children <6 years of age born preterm with birth weights <1251g who developed high-risk prethreshold retinopathy of prematurity and who participated in the Early Treatment for Retinopathy of Prematurity trial. METHODS:Surviving children from the cohort of 401 participants who had developed high-risk prethreshold ROP in one or both eyes underwent cycloplegic retinoscopy at 6 and 9 months corrected age and yearly between 2 and 6 years postnatal age. Eyes were randomized to receive treatment at high-risk prethreshold ROP or conventional management with treatment only if threshold ROP developed. Myopia (spherical equivalent ≥0.25 D) or high myopia (≥5.00 D) in eyes at 4-, 5-, and 6-year examinations was reported. RESULTS: At ages 4, 5, and 6 years, there was no difference in the percentage of eyes with myopia (range, 64.8%-69.9%) and eyes with high myopia (range, 35.3%-39.4%) between earlier treated and conventionally managed eyes. CONCLUSIONS: Approximately two-thirds of eyes with high-risk prethreshold ROP during the neonatal period are likely to be myopic into the preschool and early school years. In addition, the increase in the proportion of eyes with high myopia that had been observed in both earlier-treated and conventionally managed eyes between ages 6 months and 3 years does not continue between ages 3 and 6 years.
RCT Entities:
PURPOSE: To report the prevalence of myopia and high myopia in children <6 years of age born preterm with birth weights <1251 g who developed high-risk prethreshold retinopathy of prematurity and who participated in the Early Treatment for Retinopathy of Prematurity trial. METHODS: Surviving children from the cohort of 401 participants who had developed high-risk prethreshold ROP in one or both eyes underwent cycloplegic retinoscopy at 6 and 9 months corrected age and yearly between 2 and 6 years postnatal age. Eyes were randomized to receive treatment at high-risk prethreshold ROP or conventional management with treatment only if threshold ROP developed. Myopia (spherical equivalent ≥0.25 D) or high myopia (≥5.00 D) in eyes at 4-, 5-, and 6-year examinations was reported. RESULTS: At ages 4, 5, and 6 years, there was no difference in the percentage of eyes with myopia (range, 64.8%-69.9%) and eyes with high myopia (range, 35.3%-39.4%) between earlier treated and conventionally managed eyes. CONCLUSIONS: Approximately two-thirds of eyes with high-risk prethreshold ROP during the neonatal period are likely to be myopic into the preschool and early school years. In addition, the increase in the proportion of eyes with high myopia that had been observed in both earlier-treated and conventionally managed eyes between ages 6 months and 3 years does not continue between ages 3 and 6 years.
Authors: William V Good; Robert J Hardy; Velma Dobson; Earl A Palmer; Dale L Phelps; Betty Tung; Maryann Redford Journal: Arch Ophthalmol Date: 2010-04-12
Authors: G E Quinn; V Dobson; R Siatkowski; R J Hardy; J Kivlin; E A Palmer; D L Phelps; M X Repka; C G Summers; B Tung; W Chan Journal: Ophthalmology Date: 2001-02 Impact factor: 12.079
Authors: G E Quinn; V Dobson; M X Repka; J Reynolds; J Kivlin; B Davis; E Buckley; J T Flynn; E A Palmer Journal: Ophthalmology Date: 1992-03 Impact factor: 12.079
Authors: Bradley V Davitt; Graham E Quinn; David K Wallace; Velma Dobson; Robert J Hardy; Betty Tung; Dejian Lai; William V Good Journal: Ophthalmology Date: 2011-08-27 Impact factor: 12.079
Authors: Bradley V Davitt; Velma Dobson; William V Good; Robert J Hardy; Graham E Quinn; R Michael Siatkowski; C Gail Summers; Betty Tung Journal: Ophthalmology Date: 2005-09 Impact factor: 12.079
Authors: Robert J Hardy; Earl A Palmer; Velma Dobson; C Gail Summers; Dale L Phelps; Graham E Quinn; William V Good; Betty Tung Journal: Arch Ophthalmol Date: 2003-12
Authors: Bradley V Davitt; Velma Dobson; Graham E Quinn; Robert J Hardy; Betty Tung; William V Good Journal: Ophthalmology Date: 2008-12-16 Impact factor: 12.079
Authors: Graham E Quinn; Velma Dobson; Bradley V Davitt; Robert J Hardy; Betty Tung; Claudia Pedroza; William V Good Journal: Ophthalmology Date: 2008-06 Impact factor: 12.079
Authors: G E Quinn; V Dobson; J Kivlin; L M Kaufman; M X Repka; J D Reynolds; R A Gordon; R J Hardy; B Tung; R A Stone Journal: Ophthalmology Date: 1998-07 Impact factor: 12.079
Authors: Robert J Munro; Anne B Fulton; Toco Y P Chui; Anne Moskowitz; Ramkumar Ramamirtham; Ronald M Hansen; Sanjay P Prabhu; James D Akula Journal: Invest Ophthalmol Vis Sci Date: 2015-05 Impact factor: 4.799
Authors: Gil Binenbaum; Edward F Bell; Pamela Donohue; Graham Quinn; James Shaffer; Lauren A Tomlinson; Gui-Shuang Ying Journal: JAMA Ophthalmol Date: 2018-09-01 Impact factor: 7.389